Author:
Amelotti Ivana,Catalá Silvia S,Gorla David E
Abstract
Abstract
Background
Triatoma infestans is the main vector of Chagas disease in the Gran Chaco region of South America. The traditional spraying technique used for the application of pyrethroid insecticides has shown low efficiency in the elimination of the vector species populations occupying peridomestic structures of rural houses in the endemic area of Argentina. As part of studies looking for better alternatives, we evaluated the residual effect of insecticidal paints on the mortality of fourth instar nymphs of T. infestans.
Results
The study was based on an experimental design that included two groups treated with an organophosphate (Inesfly 5A IGR™) and a pyrethroid (Inesfly 5A IGR NG™) formulations of the paint, that were applied on wood, cement blocks and adobe bricks under natural climatic conditions. A third group was an untreated control. Both paint formulations showed very long residual activity, producing mortality of 84% and 98% (pyrethroid and organophosphate formulations, respectively) after 12 months of the paint application. After eight months, nymphs exposed during 6 hours to the painted surfaces with the pyrethroid and organophosphate formulations showed 81.33% and 100% mortality, respectively.
Conclusion
The organophosphate- and pyrethroid-based insecticidal paints showed a very long residual activity on the mortality of fourth instar nymphs of T infestans, compared with the traditional spraying technique used for the application of pyrethroid insecticides in peridomestic structures of rural houses in the endemic region for Chagas disease in the Gran Chaco of Argentina. The application of the paints by trained personnel of the vector control programmes could be considered as an alternative control tool in areas where the traditional methods have failed or showed low efficacy.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference39 articles.
1. Jannin J, Salvatella R: Estimación cuantitativa de la enfermedad de Chagas en las Américas/Quantitative estimation of Chagas Disease in the Americas. Organización Panamericana de la Salud. 2006, OPS/HDM/CD/425-06
2. Schmunis G: Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007, 102: 75-85. 10.1590/S0074-02762007005000093.
3. Guerri-Gutenberg RA, Grana DR, Ambrosio G, Milei J: Chagas cardiomiopathy: Europe is not spared!. Eur Heart J. 2008, 29: 2587-2591. 10.1093/eurheartj/ehn424.
4. Tekiel V, Alba-Soto CD, González Cappa SM, Postan M, Sánchez DO: Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine. 2009, 27: 1323-1332. 10.1016/j.vaccine.2008.12.056.
5. Cançado RJ: Long term evaluation of etiological treatment of chagas disease with Benznidazole. Rev Inst Med Trop Sao Paulo. 2002, 44: 29-37.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献